Literature DB >> 33351530

Racial/Ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019.

John K Weiser1, Yunfeng Tie, Linda Beer, Robyn Neblett Fanfair, Roy Luke Shouse.   

Abstract

BACKGROUND: Health inequities among people with HIV may be compounded by disparities in the prevalence of comorbidities associated with an increased risk of severe illness from COVID-19.
SETTING: Complex sample survey designed to produce nationally representative estimates of behavioral and clinical characteristics of adults with diagnosed HIV in the United States.
METHODS: We estimated the prevalence of having ≥1 diagnosed comorbidity associated with severe illness from COVID-19 and prevalence differences (PDs) by race/ethnicity, income level, and type of health insurance. We considered PDs ≥5 percentage points to be meaningful from a public health perspective.
RESULTS: An estimated 37.9% [95% confidence interval (CI): 36.6 to 39.2] of adults receiving HIV care had ≥1 diagnosed comorbidity associated with severe illness from COVID-19. Compared with non-Hispanic Whites, non-Hispanic Blacks or African Americans were more likely [adjusted PD, 7.8 percentage points (95% CI: 5.7 to 10.0)] and non-Hispanic Asians were less likely [adjusted PD, -13.7 percentage points (95% CI: -22.3 to -5.0)] to have ≥1 diagnosed comorbidity after adjusting for age differences. There were no meaningful differences between non-Hispanic Whites and adults in other racial/ethnic groups. Those with low income were more likely to have ≥1 diagnosed comorbidity [PD, 7.3 percentage points (95% CI: 5.1 to 9.4)].
CONCLUSIONS: Among adults receiving HIV care, non-Hispanic Blacks and those with low income were more likely to have ≥1 diagnosed comorbidity associated with severe COVID-19. Building health equity among people with HIV during the COVID-19 pandemic may require reducing the impact of comorbidities in heavily affected communities.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33351530     DOI: 10.1097/QAI.0000000000002592

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States.

Authors:  Rachel A Bender Ignacio; Adrienne E Shapiro; Robin M Nance; Bridget M Whitney; Joseph A C Delaney; Laura Bamford; Darcy Wooten; Maile Y Karris; William C Mathews; Hyang Nina Kim; Jeanne Keruly; Greer Burkholder; Sonia Napravnik; Kenneth H Mayer; Jeffrey Jacobson; Michael Saag; Richard D Moore; Joseph J Eron; Amanda L Willig; Katerina A Christopoulos; Jeffrey Martin; Peter W Hunt; Heidi M Crane; Mari M Kitahata; Edward R Cachay
Journal:  AIDS       Date:  2022-05-06       Impact factor: 4.632

2.  Multicenter Study of Outcomes Among Persons With HIV Who Presented to US Emergency Departments With Suspected SARS-CoV-2.

Authors:  Christopher L Bennett; Emmanuel Ogele; Nicholas R Pettit; Jason J Bischof; Tong Meng; Prasanthi Govindarajan; Carlos A Camargo; Kristen Nordenholz; Jeffrey A Kline
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-01       Impact factor: 3.771

3.  Prevalence and Correlates of SARS CoV-2 Among a Community-Based Sample Recruited Using Randomized Venue-Based Sampling. Essex County, NJ, 2020.

Authors:  Henry F Raymond; Pratik Datta; Rahul Ukey; Peng Wang; Richard J Martino; Kristen D Krause; Corey Rosmarin-DeStefano; Abraham Pinter; Perry N Halkitis; Maria L Gennaro
Journal:  J Racial Ethn Health Disparities       Date:  2021-11-08

4.  Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.

Authors:  R A Bender Ignacio; A E Shapiro; R M Nance; B M Whitney; Jac Delaney; L Bamford; D Wooten; M Karris; W C Mathews; H N Kim; S E Van Rompaey; J C Keruly; G Burkholder; S Napravnik; K H Mayer; J Jacobson; M S Saag; R D Moore; J J Eron; A L Willig; K A Christopoulos; J Martin; P W Hunt; H M Crane; M M Kitahata; E Cachay
Journal:  medRxiv       Date:  2021-12-08

Review 5.  COVID-19 Clinical Presentation Among HIV-Infected Persons in China: A Systematic Review.

Authors:  Dayong Huang; Jiawulan Zunong; Menglong Li; Dan Li; JiaJian Gong; Sten H Vermund; Yifei Hu
Journal:  Curr HIV/AIDS Rep       Date:  2022-04-08       Impact factor: 5.495

6.  CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study.

Authors:  Cecilia T Costiniuk; Joel Singer; Marc-André Langlois; Iva Kulic; Judy Needham; Ann Burchell; Mohammad-Ali Jenabian; Sharon Walmsley; Mario Ostrowski; Colin Kovacs; Darrell Tan; Marianne Harris; Mark Hull; Zabrina Brumme; Mark Brockman; Shari Margolese; Enrico Mandarino; Jonathan B Angel; Jean-Pierre Routy; Aslam H Anis; Curtis Cooper
Journal:  BMJ Open       Date:  2021-12-16       Impact factor: 2.692

7.  Risk of Severe COVID-19 Disease and the Pandemic's Impact on Service Utilization Among a Longitudinal Cohort of Persons with HIV-Washington, DC.

Authors:  Anne K Monroe; Jiayang Xiao; Alan E Greenberg; Matt E Levy; Marinella Temprosa; Jenna B Resnik; Amanda D Castel
Journal:  AIDS Behav       Date:  2022-04-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.